Payment Breakdown by Category
Payments by Nature
| Nature of Payment | Amount | Transactions | Share |
|---|---|---|---|
| Food and Beverage | $2,934 | 117 | 99.6% |
| Education | $11.66 | 1 | 0.4% |
Top Paying Companies
| Company | Total | Records | Latest Year |
|---|---|---|---|
| GlaxoSmithKline, LLC. | $608.62 | 34 | $0 (2024) |
| AstraZeneca Pharmaceuticals LP | $388.01 | 21 | $0 (2024) |
| Genentech USA, Inc. | $343.52 | 5 | $0 (2022) |
| Shire North American Group Inc | $243.74 | 2 | $0 (2019) |
| CSL Behring | $228.36 | 5 | $0 (2024) |
| Regeneron Healthcare Solutions, Inc. | $138.00 | 8 | $0 (2024) |
| GENZYME CORPORATION | $130.30 | 6 | $0 (2024) |
| Takeda Pharmaceuticals U.S.A., Inc. | $122.24 | 1 | $0 (2020) |
| Novartis Pharmaceuticals Corporation | $107.12 | 6 | $0 (2024) |
| kaleo, Inc. | $84.98 | 5 | $0 (2022) |
Payment History by Year
| Year | Amount | Transactions | Top Company |
|---|---|---|---|
| 2024 | $623.32 | 31 | AstraZeneca Pharmaceuticals LP ($215.12) |
| 2023 | $289.73 | 16 | AstraZeneca Pharmaceuticals LP ($78.54) |
| 2022 | $687.83 | 38 | GlaxoSmithKline, LLC. ($135.89) |
| 2021 | $264.67 | 18 | GlaxoSmithKline, LLC. ($113.19) |
| 2020 | $191.49 | 5 | Takeda Pharmaceuticals U.S.A., Inc. ($122.24) |
| 2019 | $621.03 | 8 | Genentech USA, Inc. ($125.00) |
| 2018 | $267.11 | 2 | Genentech USA, Inc. ($145.24) |
All Payment Transactions
118 individual payment records from CMS Open Payments — Page 1 of 5
| Date | Company | Product | Nature | Form | Amount | Type |
|---|---|---|---|---|---|---|
| 12/26/2024 | GlaxoSmithKline, LLC. | AREXVY (Drug), TRELEGY ELLIPTA | Food and Beverage | In-kind items and services | $15.20 | General |
| Category: RESPIRATORY | ||||||
| 12/23/2024 | AstraZeneca Pharmaceuticals LP | AIRSUPRA (Drug) | Education | In-kind items and services | $11.66 | General |
| Category: Respiratory | ||||||
| 12/05/2024 | GlaxoSmithKline, LLC. | NUCALA (Biological) | Food and Beverage | In-kind items and services | $28.19 | General |
| Category: IMMUNOLOGY | ||||||
| 12/02/2024 | AstraZeneca Pharmaceuticals LP | AIRSUPRA (Drug) | Food and Beverage | In-kind items and services | $20.48 | General |
| Category: Respiratory | ||||||
| 11/19/2024 | Amgen Inc. | TEZSPIRE (Biological) | Food and Beverage | In-kind items and services | $18.67 | General |
| Category: Inflammation | ||||||
| 11/12/2024 | AstraZeneca Pharmaceuticals LP | AIRSUPRA (Drug) | Food and Beverage | In-kind items and services | $18.21 | General |
| Category: Respiratory | ||||||
| 11/07/2024 | GlaxoSmithKline, LLC. | NUCALA (Biological) | Food and Beverage | In-kind items and services | $22.87 | General |
| Category: IMMUNOLOGY | ||||||
| 11/04/2024 | Regeneron Healthcare Solutions, Inc. | DUPIXENT (Biological) | Food and Beverage | In-kind items and services | $18.68 | General |
| Category: INFLAMMATION AND IMMUNOLOGY | ||||||
| 10/28/2024 | AstraZeneca Pharmaceuticals LP | FASENRA (Biological) | Food and Beverage | In-kind items and services | $14.42 | General |
| Category: Respiratory | ||||||
| 10/21/2024 | LEO Pharma Inc. | ADBRY (Biological) | Food and Beverage | In-kind items and services | $19.65 | General |
| Category: DERMATOLOGY | ||||||
| 10/17/2024 | AstraZeneca Pharmaceuticals LP | AIRSUPRA (Drug) | Food and Beverage | In-kind items and services | $19.36 | General |
| Category: Respiratory | ||||||
| 10/15/2024 | AstraZeneca Pharmaceuticals LP | AIRSUPRA (Drug) | Food and Beverage | In-kind items and services | $17.93 | General |
| Category: Respiratory | ||||||
| 10/01/2024 | AstraZeneca Pharmaceuticals LP | FASENRA (Biological) | Food and Beverage | In-kind items and services | $14.66 | General |
| Category: Respiratory | ||||||
| 09/09/2024 | GlaxoSmithKline, LLC. | NUCALA (Biological) | Food and Beverage | In-kind items and services | $7.40 | General |
| Category: IMMUNOLOGY | ||||||
| 08/30/2024 | AstraZeneca Pharmaceuticals LP | FASENRA (Biological) | Food and Beverage | In-kind items and services | $14.19 | General |
| Category: Respiratory | ||||||
| 08/27/2024 | GlaxoSmithKline, LLC. | AREXVY (Drug) | Food and Beverage | In-kind items and services | $21.27 | General |
| Category: RESPIRATORY | ||||||
| 08/26/2024 | Regeneron Healthcare Solutions, Inc. | DUPIXENT (Biological) | Food and Beverage | In-kind items and services | $18.72 | General |
| Category: INFLAMMATION AND IMMUNOLOGY | ||||||
| 08/21/2024 | Novartis Pharmaceuticals Corporation | XOLAIR (Drug) | Food and Beverage | In-kind items and services | $16.27 | General |
| Category: Pulmonary/Respiratory Diseases | ||||||
| 05/30/2024 | GlaxoSmithKline, LLC. | NUCALA (Biological) | Food and Beverage | In-kind items and services | $21.50 | General |
| Category: IMMUNOLOGY | ||||||
| 05/07/2024 | GlaxoSmithKline, LLC. | NUCALA (Biological) | Food and Beverage | In-kind items and services | $18.74 | General |
| Category: IMMUNOLOGY | ||||||
| 04/15/2024 | Regeneron Healthcare Solutions, Inc. | DUPIXENT (Biological) | Food and Beverage | In-kind items and services | $16.43 | General |
| Category: INFLAMMATION AND IMMUNOLOGY | ||||||
| 04/02/2024 | GENZYME CORPORATION | DUPIXENT (Biological), DUPIXENT | Food and Beverage | In-kind items and services | $21.05 | General |
| Category: Immunology | ||||||
| 03/12/2024 | GlaxoSmithKline, LLC. | TRELEGY ELLIPTA (Drug), AREXVY | Food and Beverage | In-kind items and services | $14.36 | General |
| Category: RESPIRATORY | ||||||
| 03/11/2024 | PFIZER INC. | OCTAGAM IMMUNE GLOBULIN (HUMAN) (Drug), PANZYGA, CUTAQUIG | Food and Beverage | In-kind items and services | $32.54 | General |
| Category: IMMUNOLOGY | ||||||
| 03/07/2024 | GlaxoSmithKline, LLC. | NUCALA (Biological) | Food and Beverage | In-kind items and services | $25.32 | General |
| Category: IMMUNOLOGY | ||||||
Medicare Billing by Year
| Year | Procedures | Beneficiaries | Services | Submitted | Medicare Paid |
|---|---|---|---|---|---|
| 2023 | 13 | 542 | 8,387 | $535,925 | $213,392 |
| 2022 | 11 | 370 | 4,526 | $248,326 | $116,501 |
| 2021 | 5 | 99 | 891 | $26,057 | $10,074 |
All Medicare Procedures & Services
29 procedure records from CMS Medicare Utilization — Page 1 of 2
| HCPCS | Description | Setting | Year | Patients | Services | Charges | Medicare Paid | Ratio |
|---|---|---|---|---|---|---|---|---|
| J2357 | Injection, omalizumab, 5 mg | Office | 2023 | 22 | 5,820 | $415,080 | $176,571 | 42.5% |
| 99214 | Established patient office or other outpatient visit, 30-39 minutes | Office | 2023 | 80 | 114 | $26,736 | $10,463 | 39.1% |
| 95165 | Professional service for preparation and provision of 1 or more antigens | Office | 2023 | 32 | 600 | $17,280 | $6,596 | 38.2% |
| 99213 | Established patient office or other outpatient visit, 20-29 minutes | Office | 2023 | 78 | 86 | $12,549 | $5,102 | 40.7% |
| 99204 | New patient office or other outpatient visit, 45-59 minutes | Office | 2023 | 31 | 31 | $10,017 | $3,700 | 36.9% |
| 96372 | Injection of drug or substance under skin or into muscle | Office | 2023 | 51 | 313 | $17,860 | $3,369 | 18.9% |
| 95117 | Professional service for multiple injections of allergen | Office | 2023 | 65 | 351 | $14,192 | $2,927 | 20.6% |
| 95004 | Test for allergy using allergenic extract | Office | 2023 | 15 | 752 | $10,666 | $2,293 | 21.5% |
| 95115 | Professional service for single injection of allergen | Office | 2023 | 27 | 138 | $4,380 | $1,013 | 23.1% |
| 94375 | Test to measure rate of airflow | Office | 2023 | 17 | 18 | $1,425 | $489.62 | 34.4% |
| 94060 | Test to measure expiratory airflow and volume changes before and after medication administration | Office | 2023 | 14 | 15 | $1,920 | $392.73 | 20.5% |
| 96160 | Administration and interpretation of patient-focused health risk assessment | Office | 2023 | 99 | 138 | $2,761 | $266.70 | 9.7% |
| 94010 | Test to measure expiratory airflow and volume | Office | 2023 | 11 | 11 | $1,059 | $210.00 | 19.8% |
| J2357 | Injection, omalizumab, 5 mg | Office | 2022 | 20 | 3,135 | $191,235 | $94,077 | 49.2% |
| 99214 | Established patient office or other outpatient visit, 30-39 minutes | Office | 2022 | 78 | 96 | $18,240 | $9,367 | 51.4% |
| 99204 | New patient office or other outpatient visit, 45-59 minutes | Office | 2022 | 32 | 32 | $9,280 | $3,703 | 39.9% |
| 95165 | Professional service for preparation and provision of 1 or more antigens | Office | 2022 | 17 | 225 | $6,075 | $2,701 | 44.5% |
| 95004 | Test for allergy using allergenic extract | Office | 2022 | 12 | 608 | $7,904 | $1,910 | 24.2% |
| 96372 | Injection of drug or substance under skin or into muscle | Office | 2022 | 39 | 146 | $6,570 | $1,641 | 25.0% |
| 95117 | Professional service for multiple injections of allergen | Office | 2022 | 61 | 130 | $4,160 | $1,162 | 27.9% |
| 99213 | Established patient office or other outpatient visit, 20-29 minutes | Office | 2022 | 13 | 14 | $1,848 | $1,004 | 54.3% |
| 95115 | Professional service for single injection of allergen | Office | 2022 | 27 | 54 | $1,350 | $400.21 | 29.6% |
| 87426 | Detection test by immunoassay technique for severe acute respiratory syndrome coronavirus | Office | 2022 | 11 | 11 | $1,045 | $381.53 | 36.5% |
| 96160 | Administration and interpretation of patient-focused health risk assessment | Office | 2022 | 60 | 75 | $618.75 | $154.36 | 24.9% |
| 99214 | Established patient outpatient visit, total time 30-39 minutes | Office | 2021 | 30 | 37 | $7,030 | $3,799 | 54.0% |
About Dr. Irina Dawson, M.D
Dr. Irina Dawson, M.D is a Allergy & Immunology healthcare provider based in Fredericksburg, Virginia. This provider has been registered with the National Plan and Provider Enumeration System (NPPES) since 04/06/2015. The National Provider Identifier (NPI) number assigned to this provider is 1992190946.
According to the Centers for Medicare & Medicaid Services (CMS) Open Payments database, Dr. Irina Dawson, M.D has received a total of $2,945 in payments from pharmaceutical and medical device companies, with $623.32 received in 2024. These payments were reported across 118 transactions from 24 companies. The most common payment nature is "Food and Beverage" ($2,934).
As a Medicare-enrolled provider, Dawson has provided services to 1,011 Medicare beneficiaries, totaling 13,804 services with total Medicare billing of $339,968. Data is available for 3 years (2021–2023), covering 29 distinct procedure/service records.
Practice Information
- Specialty Allergy & Immunology
- Location Fredericksburg, VA
- Active Since 04/06/2015
- Last Updated 10/31/2023
- Taxonomy Code 207K00000X
- Entity Type Individual
- NPI Number 1992190946
Products in Payments
- NUCALA (Biological) $447.47
- DUPIXENT (Biological) $284.54
- CINRYZE (Drug) $243.74
- Xolair (Biological) $218.52
- FASENRA (Biological) $166.71
- Hizentra (Biological) $144.96
- TEZSPIRE (Biological) $128.38
- AIRSUPRA (Drug) $126.95
- TRELEGY ELLIPTA (Drug) $124.68
- HYQVIA (Biological) $122.24
- AUVI-Q (Drug) $84.98
- Haegarda (Biological) $83.40
- ImmunoCAP (Device) $79.30
- Xhance (Drug) $60.06
- XOLAIR (Biological) $59.16
- PALFORZIA (Biological) $54.60
- XOLAIR (Drug) $47.96
- OPZELURA (Drug) $47.65
- AREXVY (Drug) $36.47
- ADBRY (Biological) $35.87
Explore
Data Sources
Provider data from NPPES. Payment data from CMS Open Payments. Medicare data from CMS Medicare Provider Utilization. All data is public and updated periodically.
Allergy & Immunology Doctors in Fredericksburg
Andrew Kim, M.d, M.D
Allergy & Immunology — Payments: $113,038
Dr. Ahmed Butt, M.d, M.D
Allergy & Immunology — Payments: $92,752
Dr. Julie Cooper, M.d, M.D
Allergy & Immunology — Payments: $11,008
Jonathan Mozena, M.d, M.D
Allergy & Immunology — Payments: $9,072
Jonathon Posthumus, Md, MD
Allergy & Immunology — Payments: $8,062
Mark Wenger, M. D, M. D
Allergy & Immunology — Payments: $1,902